Lancet cities lack of data authenticity: Study that paused HCQ trails now retracted

Scientists around the world are resuming trials of the controversial drug hydroxychloroquine for possible use against COVID-19, after the retraction of a heavily criticised study into its effects and side-effects. Now the paper has been retracted, and the WHO trials are back on after several of the paper's authors said they were not able to verify the contents of a database at the heart of the study.